| 1 |
Hogan KA, Zeidler JD, Beasley HK, Alsaadi AI, Alshaheeb AA, Chang Y, Tian H, Hinton AO, Mcreynolds MR. Using mass spectrometry imaging to visualize age-related subcellular disruption. Front Mol Biosci 2023;10. [DOI: 10.3389/fmolb.2023.906606] [Reference Citation Analysis]
|
| 2 |
Feuz MB, Meyer-Ficca ML, Meyer RG. Beyond Pellagra-Research Models and Strategies Addressing the Enduring Clinical Relevance of NAD Deficiency in Aging and Disease. Cells 2023;12. [PMID: 36766842 DOI: 10.3390/cells12030500] [Reference Citation Analysis]
|
| 3 |
Rai R. Cross Talk of Purinergic and Immune Signaling: Implication in Inflammatory and Pathogenic Diseases. Purinergic System 2022. [DOI: 10.5772/intechopen.104978] [Reference Citation Analysis]
|
| 4 |
Cercillieux A, Ciarlo E, Canto C. Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations. Cell Mol Life Sci 2022;79:463. [PMID: 35918544 DOI: 10.1007/s00018-022-04499-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Sulaymonov SA, Abdullayev SV. APIGENIN TIBBIY QO'SHIMCHALAR ASOSI. ЖурХимТовНарМед 2022;1:137-151. [DOI: 10.55475/jcgtm/vol1.iss3.2022.58] [Reference Citation Analysis]
|
| 6 |
Wu M, Liu F, Yan L, Huang R, Hu R, Zhu J, Li S, Long C. MiR-145-5p restrains chondrogenic differentiation of synovium-derived mesenchymal stem cells by suppressing TLR4. Nucleosides Nucleotides Nucleic Acids 2022;41:625-42. [PMID: 35403567 DOI: 10.1080/15257770.2022.2057535] [Reference Citation Analysis]
|
| 7 |
Canto C. NAD+ Precursors: A Questionable Redundancy. Metabolites 2022;12:630. [PMID: 35888754 DOI: 10.3390/metabo12070630] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Meyer-Ficca ML, Zwerdling AE, Swanson CA, Tucker AG, Lopez SA, Wandersee MK, Warner GM, Thompson KL, Chini CCS, Chen H, Chini EN, Meyer RG. Low NAD(+) Levels Are Associated With a Decline of Spermatogenesis in Transgenic ANDY and Aging Mice. Front Endocrinol (Lausanne) 2022;13:896356. [PMID: 35600581 DOI: 10.3389/fendo.2022.896356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Banerjee P, Olmsted-Davis EA, Deswal A, Nguyen MT, Koutroumpakis E, Palaskas NL, Lin SH, Kotla S, Reyes-Gibby C, Yeung SJ, Yusuf SW, Yoshimoto M, Kobayashi M, Yu B, Schadler K, Herrmann J, Cooke JP, Jain A, Chini E, Le NT, Abe JI. Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications. J Cardiovasc Aging 2022;2:28. [PMID: 35801078 DOI: 10.20517/jca.2022.13] [Reference Citation Analysis]
|
